nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Doxorubicin—thyroid cancer	0.181	0.283	CbGbCtD
Sildenafil—ABCC4—Sorafenib—thyroid cancer	0.143	0.224	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0569	0.0889	CbGbCtD
Sildenafil—CYP3A7—Sorafenib—thyroid cancer	0.0569	0.0889	CbGbCtD
Sildenafil—CYP3A5—Sorafenib—thyroid cancer	0.0427	0.0667	CbGbCtD
Sildenafil—CYP2C19—Sorafenib—thyroid cancer	0.0344	0.0538	CbGbCtD
Sildenafil—CYP2C9—Sorafenib—thyroid cancer	0.0286	0.0447	CbGbCtD
Sildenafil—CYP3A4—Vandetanib—thyroid cancer	0.0276	0.0431	CbGbCtD
Sildenafil—CYP2D6—Sorafenib—thyroid cancer	0.0262	0.0409	CbGbCtD
Sildenafil—CYP3A4—Sorafenib—thyroid cancer	0.0166	0.026	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—thyroid cancer	0.0159	0.0248	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—thyroid cancer	0.0101	0.0158	CbGbCtD
Sildenafil—PDE6C—head—thyroid cancer	0.00436	0.174	CbGeAlD
Sildenafil—PDE6H—head—thyroid cancer	0.00257	0.103	CbGeAlD
Sildenafil—PDE6G—head—thyroid cancer	0.00247	0.0988	CbGeAlD
Sildenafil—PDE6G—lymph node—thyroid cancer	0.00173	0.0692	CbGeAlD
Sildenafil—ABCC10—saliva-secreting gland—thyroid cancer	0.00138	0.0551	CbGeAlD
Sildenafil—PDE5A—thyroid gland—thyroid cancer	0.0011	0.044	CbGeAlD
Sildenafil—ADORA2A—head—thyroid cancer	0.00107	0.0429	CbGeAlD
Sildenafil—ABCC10—trachea—thyroid cancer	0.00106	0.0425	CbGeAlD
Sildenafil—ABCC5—thyroid gland—thyroid cancer	0.00101	0.0403	CbGeAlD
Sildenafil—PDE5A—head—thyroid cancer	0.000977	0.039	CbGeAlD
Sildenafil—ABCC10—thyroid gland—thyroid cancer	0.000842	0.0336	CbGeAlD
Sildenafil—ABCC4—thyroid gland—thyroid cancer	0.000698	0.0279	CbGeAlD
Sildenafil—PDE5A—lymph node—thyroid cancer	0.000684	0.0273	CbGeAlD
Sildenafil—ABCC5—lymph node—thyroid cancer	0.000626	0.025	CbGeAlD
Sildenafil—ABCC4—head—thyroid cancer	0.000619	0.0248	CbGeAlD
Sildenafil—CYP1A1—trachea—thyroid cancer	0.000592	0.0236	CbGeAlD
Sildenafil—ABCC10—lymph node—thyroid cancer	0.000523	0.0209	CbGeAlD
Sildenafil—CYP1A1—thyroid gland—thyroid cancer	0.000468	0.0187	CbGeAlD
Sildenafil—ABCC4—lymph node—thyroid cancer	0.000434	0.0173	CbGeAlD
Sildenafil—CYP2E1—thyroid gland—thyroid cancer	0.000427	0.0171	CbGeAlD
Sildenafil—CYP1A1—head—thyroid cancer	0.000415	0.0166	CbGeAlD
Sildenafil—CYP2E1—head—thyroid cancer	0.000379	0.0151	CbGeAlD
Sildenafil—CYP2D6—head—thyroid cancer	0.0003	0.012	CbGeAlD
Sildenafil—CYP1A1—lymph node—thyroid cancer	0.000291	0.0116	CbGeAlD
Sildenafil—Pruritus—Sorafenib—thyroid cancer	0.00027	0.000894	CcSEcCtD
Sildenafil—Ataxia—Epirubicin—thyroid cancer	0.000269	0.000893	CcSEcCtD
Sildenafil—Pain in extremity—Doxorubicin—thyroid cancer	0.000265	0.000879	CcSEcCtD
Sildenafil—Osteoarthritis—Doxorubicin—thyroid cancer	0.000265	0.000879	CcSEcCtD
Sildenafil—Diplopia—Doxorubicin—thyroid cancer	0.000265	0.000879	CcSEcCtD
Sildenafil—Liver function test abnormal—Epirubicin—thyroid cancer	0.000264	0.000877	CcSEcCtD
Sildenafil—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000262	0.000868	CcSEcCtD
Sildenafil—Abdominal pain upper—Epirubicin—thyroid cancer	0.000262	0.000868	CcSEcCtD
Sildenafil—Migraine—Doxorubicin—thyroid cancer	0.000261	0.000865	CcSEcCtD
Sildenafil—Hypokalaemia—Epirubicin—thyroid cancer	0.000261	0.000865	CcSEcCtD
Sildenafil—Diarrhoea—Sorafenib—thyroid cancer	0.000261	0.000865	CcSEcCtD
Sildenafil—Breast disorder—Epirubicin—thyroid cancer	0.000259	0.000859	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000258	0.000856	CcSEcCtD
Sildenafil—Nasopharyngitis—Epirubicin—thyroid cancer	0.000256	0.00085	CcSEcCtD
Sildenafil—Face oedema—Doxorubicin—thyroid cancer	0.000256	0.000849	CcSEcCtD
Sildenafil—Gastritis—Epirubicin—thyroid cancer	0.000254	0.000841	CcSEcCtD
Sildenafil—Muscular weakness—Epirubicin—thyroid cancer	0.000253	0.000838	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000253	0.000838	CcSEcCtD
Sildenafil—Cardiac arrest—Doxorubicin—thyroid cancer	0.000252	0.000836	CcSEcCtD
Sildenafil—Dizziness—Sorafenib—thyroid cancer	0.000252	0.000836	CcSEcCtD
Sildenafil—Abdominal distension—Epirubicin—thyroid cancer	0.000249	0.000827	CcSEcCtD
Sildenafil—Ataxia—Doxorubicin—thyroid cancer	0.000249	0.000827	CcSEcCtD
Sildenafil—Asthma—Epirubicin—thyroid cancer	0.000248	0.000821	CcSEcCtD
Sildenafil—Dysphagia—Epirubicin—thyroid cancer	0.000248	0.000821	CcSEcCtD
Sildenafil—Influenza—Epirubicin—thyroid cancer	0.000248	0.000821	CcSEcCtD
Sildenafil—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000245	0.000812	CcSEcCtD
Sildenafil—Vomiting—Sorafenib—thyroid cancer	0.000242	0.000803	CcSEcCtD
Sildenafil—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000242	0.000803	CcSEcCtD
Sildenafil—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000242	0.000803	CcSEcCtD
Sildenafil—Hypokalaemia—Doxorubicin—thyroid cancer	0.000241	0.0008	CcSEcCtD
Sildenafil—Angina pectoris—Epirubicin—thyroid cancer	0.000241	0.0008	CcSEcCtD
Sildenafil—Rash—Sorafenib—thyroid cancer	0.00024	0.000797	CcSEcCtD
Sildenafil—Dermatitis—Sorafenib—thyroid cancer	0.00024	0.000796	CcSEcCtD
Sildenafil—Breast disorder—Doxorubicin—thyroid cancer	0.00024	0.000795	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000239	0.000792	CcSEcCtD
Sildenafil—Headache—Sorafenib—thyroid cancer	0.000239	0.000792	CcSEcCtD
Sildenafil—Bronchitis—Epirubicin—thyroid cancer	0.000238	0.00079	CcSEcCtD
Sildenafil—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000237	0.000786	CcSEcCtD
Sildenafil—Gastritis—Doxorubicin—thyroid cancer	0.000235	0.000778	CcSEcCtD
Sildenafil—Muscular weakness—Doxorubicin—thyroid cancer	0.000234	0.000775	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000234	0.000775	CcSEcCtD
Sildenafil—Abdominal distension—Doxorubicin—thyroid cancer	0.000231	0.000765	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00023	0.000763	CcSEcCtD
Sildenafil—Asthma—Doxorubicin—thyroid cancer	0.000229	0.00076	CcSEcCtD
Sildenafil—Influenza—Doxorubicin—thyroid cancer	0.000229	0.00076	CcSEcCtD
Sildenafil—Dysphagia—Doxorubicin—thyroid cancer	0.000229	0.00076	CcSEcCtD
Sildenafil—Pollakiuria—Epirubicin—thyroid cancer	0.000229	0.000759	CcSEcCtD
Sildenafil—Nausea—Sorafenib—thyroid cancer	0.000226	0.000751	CcSEcCtD
Sildenafil—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000226	0.00075	CcSEcCtD
Sildenafil—Weight increased—Epirubicin—thyroid cancer	0.000225	0.000747	CcSEcCtD
Sildenafil—Hyperglycaemia—Epirubicin—thyroid cancer	0.000223	0.000741	CcSEcCtD
Sildenafil—Angina pectoris—Doxorubicin—thyroid cancer	0.000223	0.00074	CcSEcCtD
Sildenafil—Pneumonia—Epirubicin—thyroid cancer	0.000222	0.000737	CcSEcCtD
Sildenafil—Infestation—Epirubicin—thyroid cancer	0.000221	0.000732	CcSEcCtD
Sildenafil—Infestation NOS—Epirubicin—thyroid cancer	0.000221	0.000732	CcSEcCtD
Sildenafil—Bronchitis—Doxorubicin—thyroid cancer	0.00022	0.000731	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000219	0.000726	CcSEcCtD
Sildenafil—Renal failure—Epirubicin—thyroid cancer	0.000217	0.00072	CcSEcCtD
Sildenafil—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000216	0.000718	CcSEcCtD
Sildenafil—Stomatitis—Epirubicin—thyroid cancer	0.000215	0.000714	CcSEcCtD
Sildenafil—Conjunctivitis—Epirubicin—thyroid cancer	0.000215	0.000712	CcSEcCtD
Sildenafil—Urinary tract infection—Epirubicin—thyroid cancer	0.000215	0.000712	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000213	0.000706	CcSEcCtD
Sildenafil—Sweating—Epirubicin—thyroid cancer	0.000212	0.000702	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—thyroid cancer	0.000212	0.000702	CcSEcCtD
Sildenafil—Haematuria—Epirubicin—thyroid cancer	0.00021	0.000698	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000209	0.000694	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—thyroid cancer	0.000208	0.000692	CcSEcCtD
Sildenafil—Epistaxis—Epirubicin—thyroid cancer	0.000208	0.000691	CcSEcCtD
Sildenafil—Sinusitis—Epirubicin—thyroid cancer	0.000207	0.000687	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000207	0.000685	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—thyroid cancer	0.000205	0.000681	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—thyroid cancer	0.000204	0.000678	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—thyroid cancer	0.000204	0.000678	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000203	0.000672	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—thyroid cancer	0.000201	0.000666	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.0002	0.000664	CcSEcCtD
Sildenafil—Haemoglobin—Epirubicin—thyroid cancer	0.000199	0.000661	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—thyroid cancer	0.000199	0.00066	CcSEcCtD
Sildenafil—Rhinitis—Epirubicin—thyroid cancer	0.000199	0.000659	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—thyroid cancer	0.000199	0.000659	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—thyroid cancer	0.000199	0.000659	CcSEcCtD
Sildenafil—Haemorrhage—Epirubicin—thyroid cancer	0.000198	0.000657	CcSEcCtD
Sildenafil—Hypoaesthesia—Epirubicin—thyroid cancer	0.000197	0.000654	CcSEcCtD
Sildenafil—Pharyngitis—Epirubicin—thyroid cancer	0.000197	0.000652	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—thyroid cancer	0.000196	0.00065	CcSEcCtD
Sildenafil—Urinary tract disorder—Epirubicin—thyroid cancer	0.000196	0.000649	CcSEcCtD
Sildenafil—Oedema peripheral—Epirubicin—thyroid cancer	0.000195	0.000648	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—thyroid cancer	0.000195	0.000646	CcSEcCtD
Sildenafil—Connective tissue disorder—Epirubicin—thyroid cancer	0.000195	0.000646	CcSEcCtD
Sildenafil—Urethral disorder—Epirubicin—thyroid cancer	0.000194	0.000644	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—thyroid cancer	0.000193	0.000639	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—thyroid cancer	0.000192	0.000636	CcSEcCtD
Sildenafil—Visual impairment—Epirubicin—thyroid cancer	0.000191	0.000633	CcSEcCtD
Sildenafil—Erythema multiforme—Epirubicin—thyroid cancer	0.000187	0.000622	CcSEcCtD
Sildenafil—Eye disorder—Epirubicin—thyroid cancer	0.000185	0.000614	CcSEcCtD
Sildenafil—Tinnitus—Epirubicin—thyroid cancer	0.000185	0.000613	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—thyroid cancer	0.000184	0.000611	CcSEcCtD
Sildenafil—Flushing—Epirubicin—thyroid cancer	0.000184	0.00061	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—thyroid cancer	0.000184	0.00061	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—thyroid cancer	0.000184	0.00061	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—thyroid cancer	0.000183	0.000608	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000182	0.000605	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—thyroid cancer	0.000182	0.000604	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000181	0.000601	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—thyroid cancer	0.000181	0.000599	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00018	0.000598	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—thyroid cancer	0.00018	0.000596	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—thyroid cancer	0.00018	0.000596	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—thyroid cancer	0.000179	0.000594	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—thyroid cancer	0.000179	0.000592	CcSEcCtD
Sildenafil—Chills—Epirubicin—thyroid cancer	0.000178	0.00059	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—thyroid cancer	0.000177	0.000587	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—thyroid cancer	0.000177	0.000586	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—thyroid cancer	0.000175	0.000581	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—thyroid cancer	0.000174	0.000576	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—thyroid cancer	0.000173	0.000575	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—thyroid cancer	0.000173	0.000572	CcSEcCtD
Sildenafil—Erythema—Epirubicin—thyroid cancer	0.000173	0.000572	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—thyroid cancer	0.000171	0.000568	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—thyroid cancer	0.000171	0.000567	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—thyroid cancer	0.00017	0.000564	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—thyroid cancer	0.00017	0.000564	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—thyroid cancer	0.00017	0.000564	CcSEcCtD
Sildenafil—Tension—Epirubicin—thyroid cancer	0.000169	0.000562	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—thyroid cancer	0.000168	0.000556	CcSEcCtD
Sildenafil—Back pain—Epirubicin—thyroid cancer	0.000167	0.000554	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—thyroid cancer	0.000166	0.000552	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—thyroid cancer	0.000166	0.000549	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000165	0.000548	CcSEcCtD
Sildenafil—Chills—Doxorubicin—thyroid cancer	0.000165	0.000546	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—thyroid cancer	0.000164	0.000543	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—thyroid cancer	0.000163	0.000539	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—thyroid cancer	0.000162	0.000537	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—thyroid cancer	0.000161	0.000533	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—thyroid cancer	0.00016	0.000531	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—thyroid cancer	0.00016	0.000529	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—thyroid cancer	0.00016	0.000529	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—thyroid cancer	0.000159	0.000529	CcSEcCtD
Sildenafil—Agitation—Epirubicin—thyroid cancer	0.000159	0.000526	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—thyroid cancer	0.000157	0.000522	CcSEcCtD
Sildenafil—Tension—Doxorubicin—thyroid cancer	0.000157	0.00052	CcSEcCtD
Sildenafil—Malaise—Epirubicin—thyroid cancer	0.000156	0.000516	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—thyroid cancer	0.000155	0.000514	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—thyroid cancer	0.000155	0.000514	CcSEcCtD
Sildenafil—Syncope—Epirubicin—thyroid cancer	0.000155	0.000513	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—thyroid cancer	0.000154	0.000512	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—thyroid cancer	0.000154	0.000512	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—thyroid cancer	0.000152	0.000506	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—thyroid cancer	0.000152	0.000503	CcSEcCtD
Sildenafil—Cough—Epirubicin—thyroid cancer	0.000151	0.000499	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—thyroid cancer	0.00015	0.000499	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—thyroid cancer	0.000149	0.000496	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—thyroid cancer	0.000149	0.000494	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000148	0.000491	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—thyroid cancer	0.000148	0.000489	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—thyroid cancer	0.000147	0.000487	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—thyroid cancer	0.000147	0.000487	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—thyroid cancer	0.000147	0.000487	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—thyroid cancer	0.000147	0.000487	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—thyroid cancer	0.000146	0.000485	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000146	0.000484	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—thyroid cancer	0.000145	0.000481	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—thyroid cancer	0.000144	0.000477	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—thyroid cancer	0.000144	0.000476	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—thyroid cancer	0.000143	0.000476	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—thyroid cancer	0.000143	0.000475	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—thyroid cancer	0.000143	0.000474	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—thyroid cancer	0.000141	0.000468	CcSEcCtD
Sildenafil—Oedema—Epirubicin—thyroid cancer	0.000141	0.000467	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—thyroid cancer	0.00014	0.000465	CcSEcCtD
Sildenafil—Infection—Epirubicin—thyroid cancer	0.00014	0.000464	CcSEcCtD
Sildenafil—Cough—Doxorubicin—thyroid cancer	0.000139	0.000462	CcSEcCtD
Sildenafil—Shock—Epirubicin—thyroid cancer	0.000139	0.000459	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—thyroid cancer	0.000138	0.000459	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—thyroid cancer	0.000138	0.000458	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—thyroid cancer	0.000138	0.000457	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—thyroid cancer	0.000137	0.000456	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—thyroid cancer	0.000137	0.000454	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—thyroid cancer	0.000136	0.000451	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—thyroid cancer	0.000136	0.000451	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—thyroid cancer	0.000136	0.000451	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—thyroid cancer	0.000136	0.000451	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—thyroid cancer	0.000135	0.000449	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000135	0.000448	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—thyroid cancer	0.000134	0.000445	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—thyroid cancer	0.000134	0.000445	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—thyroid cancer	0.000133	0.000441	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—thyroid cancer	0.000132	0.000436	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—thyroid cancer	0.00013	0.000432	CcSEcCtD
Sildenafil—Infection—Doxorubicin—thyroid cancer	0.000129	0.000429	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000128	0.000425	CcSEcCtD
Sildenafil—Shock—Doxorubicin—thyroid cancer	0.000128	0.000425	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—thyroid cancer	0.000128	0.000424	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—thyroid cancer	0.000127	0.000422	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—thyroid cancer	0.000127	0.000422	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—thyroid cancer	0.000127	0.00042	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—thyroid cancer	0.000126	0.000419	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000126	0.000418	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—thyroid cancer	0.000126	0.000416	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—thyroid cancer	0.000125	0.000415	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—thyroid cancer	0.000124	0.000412	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—thyroid cancer	0.000124	0.000411	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—thyroid cancer	0.000122	0.000406	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—thyroid cancer	0.000122	0.000404	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000122	0.000403	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—thyroid cancer	0.000121	0.000403	CcSEcCtD
Sildenafil—Pain—Epirubicin—thyroid cancer	0.00012	0.000399	CcSEcCtD
Sildenafil—Constipation—Epirubicin—thyroid cancer	0.00012	0.000399	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000119	0.000394	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—thyroid cancer	0.000118	0.000391	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—thyroid cancer	0.000117	0.000388	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—thyroid cancer	0.000116	0.000385	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—thyroid cancer	0.000116	0.000385	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—thyroid cancer	0.000116	0.000384	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000115	0.000382	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—thyroid cancer	0.000115	0.00038	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—thyroid cancer	0.000113	0.000376	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000112	0.000373	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—thyroid cancer	0.000112	0.000373	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—thyroid cancer	0.000112	0.000371	CcSEcCtD
Sildenafil—Pain—Doxorubicin—thyroid cancer	0.000111	0.00037	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—thyroid cancer	0.000111	0.00037	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—thyroid cancer	0.000111	0.000369	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—thyroid cancer	0.000111	0.000369	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—thyroid cancer	0.000107	0.000356	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000107	0.000353	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—thyroid cancer	0.000104	0.000344	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—thyroid cancer	0.000103	0.000343	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—thyroid cancer	0.000103	0.000342	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—thyroid cancer	0.000103	0.000342	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—thyroid cancer	0.000101	0.000335	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—thyroid cancer	9.96e-05	0.00033	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—thyroid cancer	9.63e-05	0.00032	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—thyroid cancer	9.6e-05	0.000318	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—thyroid cancer	9.35e-05	0.00031	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—thyroid cancer	9.31e-05	0.000309	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—thyroid cancer	9.22e-05	0.000306	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—thyroid cancer	8.95e-05	0.000297	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—thyroid cancer	8.91e-05	0.000296	CcSEcCtD
Sildenafil—Rash—Epirubicin—thyroid cancer	8.88e-05	0.000294	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—thyroid cancer	8.87e-05	0.000294	CcSEcCtD
Sildenafil—Headache—Epirubicin—thyroid cancer	8.82e-05	0.000293	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—thyroid cancer	8.61e-05	0.000286	CcSEcCtD
Sildenafil—Nausea—Epirubicin—thyroid cancer	8.36e-05	0.000277	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—thyroid cancer	8.28e-05	0.000275	CcSEcCtD
Sildenafil—Rash—Doxorubicin—thyroid cancer	8.21e-05	0.000272	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—thyroid cancer	8.21e-05	0.000272	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—TSHR—thyroid cancer	8.18e-05	0.00245	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—thyroid cancer	8.18e-05	0.00244	CbGpPWpGaD
Sildenafil—Headache—Doxorubicin—thyroid cancer	8.16e-05	0.000271	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—PRKAR1A—thyroid cancer	8.05e-05	0.00241	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDK1—thyroid cancer	7.92e-05	0.00237	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	7.82e-05	0.00234	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	7.82e-05	0.00234	CbGpPWpGaD
Sildenafil—Nausea—Doxorubicin—thyroid cancer	7.74e-05	0.000257	CcSEcCtD
Sildenafil—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.69e-05	0.0023	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MEN1—thyroid cancer	7.69e-05	0.0023	CbGpPWpGaD
Sildenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.64e-05	0.00228	CbGpPWpGaD
Sildenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	7.6e-05	0.00227	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CALCB—thyroid cancer	7.54e-05	0.00225	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.42e-05	0.00222	CbGpPWpGaD
Sildenafil—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.3e-05	0.00218	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MINPP1—thyroid cancer	7.19e-05	0.00215	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TRIM33—thyroid cancer	7.15e-05	0.00214	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.11e-05	0.00212	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.1e-05	0.00212	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—RXRA—thyroid cancer	7.09e-05	0.00212	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—RXRA—thyroid cancer	7.08e-05	0.00212	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTCH1—thyroid cancer	6.96e-05	0.00208	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—RXRA—thyroid cancer	6.69e-05	0.002	CbGpPWpGaD
Sildenafil—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.66e-05	0.00199	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—TSHR—thyroid cancer	6.51e-05	0.00195	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	6.45e-05	0.00193	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.39e-05	0.00191	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SST—thyroid cancer	6.36e-05	0.0019	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NRG1—thyroid cancer	6.36e-05	0.0019	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TPR—thyroid cancer	6.31e-05	0.00189	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—BRAF—thyroid cancer	6.29e-05	0.00188	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PRKAR1A—thyroid cancer	6.21e-05	0.00185	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	6.19e-05	0.00185	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CALCA—thyroid cancer	6.13e-05	0.00183	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NDUFA13—thyroid cancer	6.12e-05	0.00183	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	6.04e-05	0.0018	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MEN1—thyroid cancer	5.93e-05	0.00177	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—TSHR—thyroid cancer	5.91e-05	0.00177	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	5.91e-05	0.00177	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IFNA2—thyroid cancer	5.89e-05	0.00176	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—PTEN—thyroid cancer	5.87e-05	0.00176	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.85e-05	0.00175	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.82e-05	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PRKAR1A—thyroid cancer	5.82e-05	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—thyroid cancer	5.76e-05	0.00172	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CHST14—thyroid cancer	5.75e-05	0.00172	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—NRAS—thyroid cancer	5.72e-05	0.00171	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TERT—thyroid cancer	5.71e-05	0.00171	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDK1—thyroid cancer	5.54e-05	0.00166	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—AKT1—thyroid cancer	5.51e-05	0.00165	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—RXRA—thyroid cancer	5.47e-05	0.00164	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HIF1A—thyroid cancer	5.46e-05	0.00163	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.43e-05	0.00162	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.3e-05	0.00158	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—TPR—thyroid cancer	5.28e-05	0.00158	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MINPP1—thyroid cancer	5.21e-05	0.00156	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MINPP1—thyroid cancer	5.2e-05	0.00155	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PRKAR1A—thyroid cancer	5.2e-05	0.00155	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	5.14e-05	0.00154	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—SST—thyroid cancer	5.06e-05	0.00151	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—RXRA—thyroid cancer	5.03e-05	0.0015	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PTCH1—thyroid cancer	5.03e-05	0.0015	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—RXRA—thyroid cancer	4.99e-05	0.00149	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—KRAS—thyroid cancer	4.92e-05	0.00147	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.92e-05	0.00147	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MINPP1—thyroid cancer	4.91e-05	0.00147	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CALCA—thyroid cancer	4.87e-05	0.00146	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TCF7L1—thyroid cancer	4.77e-05	0.00143	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CALCA—thyroid cancer	4.72e-05	0.00141	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HPGD—thyroid cancer	4.64e-05	0.00139	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—SST—thyroid cancer	4.6e-05	0.00137	CbGpPWpGaD
Sildenafil—PDE6G—Disease—BRAF—thyroid cancer	4.52e-05	0.00135	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NRG1—thyroid cancer	4.45e-05	0.00133	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NDUFA13—thyroid cancer	4.43e-05	0.00132	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PTEN—thyroid cancer	4.43e-05	0.00132	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CALCA—thyroid cancer	4.43e-05	0.00132	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	4.42e-05	0.00132	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NDUFA13—thyroid cancer	4.42e-05	0.00132	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—thyroid cancer	4.37e-05	0.00131	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDK1—thyroid cancer	4.28e-05	0.00128	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—HRAS—thyroid cancer	4.18e-05	0.00125	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NDUFA13—thyroid cancer	4.18e-05	0.00125	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CHST14—thyroid cancer	4.17e-05	0.00124	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CHST14—thyroid cancer	4.16e-05	0.00124	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	4.07e-05	0.00122	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.02e-05	0.0012	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—thyroid cancer	4.01e-05	0.0012	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CDK1—thyroid cancer	4.01e-05	0.0012	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TERT—thyroid cancer	4e-05	0.00119	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SLC5A5—thyroid cancer	3.96e-05	0.00118	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—NRAS—thyroid cancer	3.95e-05	0.00118	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CHST14—thyroid cancer	3.93e-05	0.00117	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HIF1A—thyroid cancer	3.82e-05	0.00114	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	3.76e-05	0.00112	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.7e-05	0.0011	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—AKT1—thyroid cancer	3.69e-05	0.0011	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.67e-05	0.0011	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTGS2—thyroid cancer	3.65e-05	0.00109	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TSHR—thyroid cancer	3.49e-05	0.00104	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PRKAR1A—thyroid cancer	3.44e-05	0.00103	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NRG1—thyroid cancer	3.43e-05	0.00103	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.42e-05	0.00102	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—KRAS—thyroid cancer	3.4e-05	0.00102	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HPGD—thyroid cancer	3.36e-05	0.001	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HPGD—thyroid cancer	3.35e-05	0.001	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—RXRA—thyroid cancer	3.32e-05	0.000993	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	3.32e-05	0.000992	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.29e-05	0.000983	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MEN1—thyroid cancer	3.28e-05	0.000981	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CHST14—thyroid cancer	3.21e-05	0.00096	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTEN—thyroid cancer	3.18e-05	0.000951	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HPGD—thyroid cancer	3.17e-05	0.000946	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—BRAF—thyroid cancer	3.16e-05	0.000946	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.14e-05	0.000939	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.12e-05	0.000931	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TERT—thyroid cancer	3.08e-05	0.000921	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTCH1—thyroid cancer	2.97e-05	0.000887	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CHST14—thyroid cancer	2.96e-05	0.000883	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HIF1A—thyroid cancer	2.95e-05	0.000881	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CHST14—thyroid cancer	2.93e-05	0.000876	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—HRAS—thyroid cancer	2.89e-05	0.000864	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NRAS—thyroid cancer	2.84e-05	0.000849	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.75e-05	0.000822	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SST—thyroid cancer	2.72e-05	0.000812	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TPR—thyroid cancer	2.66e-05	0.000796	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.62e-05	0.000783	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CALCA—thyroid cancer	2.61e-05	0.000781	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HPGD—thyroid cancer	2.59e-05	0.000774	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.57e-05	0.000767	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—AKT1—thyroid cancer	2.55e-05	0.000763	CbGpPWpGaD
Sildenafil—PDE6G—Disease—KRAS—thyroid cancer	2.44e-05	0.00073	CbGpPWpGaD
Sildenafil—ABCC5—Disease—BRAF—thyroid cancer	2.44e-05	0.000729	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.42e-05	0.000722	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HPGD—thyroid cancer	2.38e-05	0.000712	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDK1—thyroid cancer	2.37e-05	0.000707	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HPGD—thyroid cancer	2.36e-05	0.000706	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCND1—thyroid cancer	2.31e-05	0.00069	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTEN—thyroid cancer	2.23e-05	0.000666	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NRAS—thyroid cancer	2.2e-05	0.000656	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.1e-05	0.000628	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PPARG—thyroid cancer	2.1e-05	0.000627	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—thyroid cancer	2.08e-05	0.000621	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.06e-05	0.000614	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.99e-05	0.000596	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NRAS—thyroid cancer	1.99e-05	0.000594	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—thyroid cancer	1.97e-05	0.000589	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CHST14—thyroid cancer	1.93e-05	0.000577	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TPR—thyroid cancer	1.93e-05	0.000576	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TPR—thyroid cancer	1.92e-05	0.000575	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.92e-05	0.000573	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRG1—thyroid cancer	1.9e-05	0.000568	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.9e-05	0.000567	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.89e-05	0.000566	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—thyroid cancer	1.89e-05	0.000565	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—thyroid cancer	1.83e-05	0.000548	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TPR—thyroid cancer	1.82e-05	0.000543	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.79e-05	0.000535	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—thyroid cancer	1.72e-05	0.000514	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—thyroid cancer	1.71e-05	0.000511	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TERT—thyroid cancer	1.71e-05	0.00051	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—thyroid cancer	1.68e-05	0.000502	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—RXRA—thyroid cancer	1.67e-05	0.0005	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—thyroid cancer	1.65e-05	0.000493	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HIF1A—thyroid cancer	1.63e-05	0.000487	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.62e-05	0.000484	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—thyroid cancer	1.61e-05	0.00048	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HPGD—thyroid cancer	1.56e-05	0.000465	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NRAS—thyroid cancer	1.53e-05	0.000458	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—thyroid cancer	1.52e-05	0.000455	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TPR—thyroid cancer	1.49e-05	0.000445	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.46e-05	0.000437	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—thyroid cancer	1.45e-05	0.000435	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.44e-05	0.000431	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.44e-05	0.00043	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—thyroid cancer	1.44e-05	0.00043	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—NRAS—thyroid cancer	1.44e-05	0.000429	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—thyroid cancer	1.42e-05	0.000424	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TPR—thyroid cancer	1.37e-05	0.000409	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.36e-05	0.000407	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TPR—thyroid cancer	1.36e-05	0.000405	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—thyroid cancer	1.35e-05	0.000404	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.35e-05	0.000402	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.33e-05	0.000399	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.33e-05	0.000396	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—thyroid cancer	1.32e-05	0.000394	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—thyroid cancer	1.28e-05	0.000384	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.28e-05	0.000381	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—thyroid cancer	1.24e-05	0.00037	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—RXRA—thyroid cancer	1.21e-05	0.000362	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—RXRA—thyroid cancer	1.21e-05	0.000362	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.21e-05	0.000361	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000342	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—thyroid cancer	1.12e-05	0.000335	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000333	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.11e-05	0.000332	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—thyroid cancer	1.06e-05	0.000316	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—thyroid cancer	1.05e-05	0.000314	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.04e-05	0.000312	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.02e-05	0.000306	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.02e-05	0.000305	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.02e-05	0.000303	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—thyroid cancer	9.91e-06	0.000296	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—thyroid cancer	9.86e-06	0.000295	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.52e-06	0.000284	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—thyroid cancer	9.52e-06	0.000284	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—RXRA—thyroid cancer	9.36e-06	0.00028	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—thyroid cancer	9.28e-06	0.000277	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.1e-06	0.000272	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TPR—thyroid cancer	8.95e-06	0.000267	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.8e-06	0.000263	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RXRA—thyroid cancer	8.61e-06	0.000257	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RXRA—thyroid cancer	8.53e-06	0.000255	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—thyroid cancer	8.49e-06	0.000254	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—thyroid cancer	8.32e-06	0.000249	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.3e-06	0.000248	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—thyroid cancer	8.3e-06	0.000248	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—thyroid cancer	7.66e-06	0.000229	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—thyroid cancer	7.64e-06	0.000228	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—thyroid cancer	7.31e-06	0.000218	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—thyroid cancer	7.25e-06	0.000217	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—thyroid cancer	7.22e-06	0.000216	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.7e-06	0.0002	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—thyroid cancer	6.49e-06	0.000194	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—thyroid cancer	6.21e-06	0.000186	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—thyroid cancer	6.02e-06	0.00018	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—thyroid cancer	6.01e-06	0.00018	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—thyroid cancer	5.91e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—thyroid cancer	5.68e-06	0.00017	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RXRA—thyroid cancer	5.63e-06	0.000168	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—thyroid cancer	5.48e-06	0.000164	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—thyroid cancer	5.43e-06	0.000162	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—thyroid cancer	5.39e-06	0.000161	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—thyroid cancer	5.25e-06	0.000157	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—thyroid cancer	5.24e-06	0.000157	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—thyroid cancer	4.95e-06	0.000148	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.65e-06	0.000139	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.27e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.24e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—thyroid cancer	4.18e-06	0.000125	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—thyroid cancer	4.05e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—thyroid cancer	3.73e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—thyroid cancer	3.7e-06	0.00011	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—thyroid cancer	3.55e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—thyroid cancer	3.03e-06	9.05e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—thyroid cancer	3.02e-06	9.03e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—thyroid cancer	2.85e-06	8.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.8e-06	8.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—thyroid cancer	2.44e-06	7.28e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—thyroid cancer	2.34e-06	6.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—thyroid cancer	2.15e-06	6.42e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—thyroid cancer	2.13e-06	6.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—thyroid cancer	1.4e-06	4.2e-05	CbGpPWpGaD
